Matthew joined TopiVert at its inception in 2011 to spearhead its medicinal chemistry, CMC and intellectual property activities. He has 16 years of experience as a medicinal chemist and drug discoverer, having formerly held the position of Director of Drug Discovery at Oryzon in Barcelona and Director of Medicinal Chemistry at Prosidion in Oxford. Matthew successfully led multiple projects in different therapeutic areas that have been purchased by major pharma companies. Matthew obtained degrees from the University of Glasgow (BSc), Columbia University (MA) and the University of Birmingham (PhD) prior to postdoctoral studies at UCLA. He is a Chartered Chemist, a Fellow of The Royal Society of Chemistry, an author of more than 40 peer-reviewed publications and an inventor on over 70 patent applications. Matthew joined TopiVert at its inception in 2011 to spearhead its medicinal chemistry, CMC and intellectual property activities. He has 16 years of experience as a medicinal chemist and drug discoverer, having formerly held the position of Director of Drug Discovery at Oryzon in Barcelona and Director of Medicinal Chemistry at Prosidion in Oxford. Matthew successfully led multiple projects in different therapeutic areas that have been purchased by major pharma companies. Matthew obtained degrees from the University of Glasgow (BSc), Columbia University (MA) and the University of Birmingham (PhD) prior to postdoctoral studies at UCLA. He is a Chartered Chemist, a Fellow of The Royal Society of Chemistry, an author of more than 40 peer-reviewed publications and an inventor on over 70 patent applications.

fermentation